HomeCompareNHLG vs ABBV

NHLG vs ABBV: Dividend Comparison 2026

NHLG yields 500000.00% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHLG wins by $4.663521010693878e+33M in total portfolio value
10 years
NHLG
NHLG
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full NHLG calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — NHLG vs ABBV

📍 NHLG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHLGABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHLG + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHLG pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHLG
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, NHLG beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHLG + ABBV for your $10,000?

NHLG: 50%ABBV: 50%
100% ABBV50/50100% NHLG
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

NHLG
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHLG buys
0
ABBV buys
0
No recent congressional trades found for NHLG or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHLGABBV
Forward yield500000.00%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$4.663521010693878e+33M$102.3K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$24,771.77
Total dividends collected$4.6634009849658873e+33M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NHLG vs ABBV ($10,000, DRIP)

YearNHLG PortfolioNHLG Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,550$430.00+$50.00MNHLG
2$233,748,371,262$233,694,859,813.08$13,472$627.96+$233748.36MNHLG
3$1,021,074,511,412,696$1,020,824,400,655,446.10$15,906$926.08+$1021074511.40MNHLG
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$19,071$1,382.55+$4168597328794.93MNHLG
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$23,302$2,095.81+$15905475114600664.00MNHLG
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$29,150$3,237.93+$56718938532531060736.00MNHLG
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$37,536$5,121.41+$1.8903180743562385e+23MNHLG
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$50,079$8,338.38+$5.8879981047651824e+26MNHLG
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$69,753$14,065.80+$1.7140642681147225e+30MNHLG
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$102,337$24,771.77+$4.663521010693878e+33MNHLG

NHLG vs ABBV: Complete Analysis 2026

NHLGStock

National Healthcare Logistics Inc. engages in contracting with healthcare providers to reengineer logistical processes for supply chain management. The company, formerly known as BCH Systems, Inc, was incorporated in 1999 and changed its name to National Healthcare Logistics Inc. in 2005. National Healthcare Logistics Inc. is based in Cleveland, Tennessee.

Full NHLG Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this NHLG vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHLG vs SCHDNHLG vs JEPINHLG vs ONHLG vs KONHLG vs MAINNHLG vs JNJNHLG vs MRKNHLG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.